D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely III medical patients: insights from the APEX trial Gibson, C. M., Arbetter, D. F., Jain, P., Halaby, R., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Harrington, R. A., Goldhaber, S. Z., Hull, R. D., Gold, A., Cohen, A. T. OXFORD UNIV PRESS. 2017: 326

View details for Web of Science ID 000440509301251